Tabitha Mahungu
Overview
Explore the profile of Tabitha Mahungu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
591
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saigal A, Nagoda Niklewicz C, Naidu S, Bintalib H, Shah A, Seligmann G, et al.
BMJ Open Respir Res
. 2023 Aug;
10(1).
PMID: 37536948
Objectives: COVID-19 studies report on hospital admission outcomes across SARS-CoV-2 waves of infection but knowledge of the impact of SARS-CoV-2 variants on the development of Long COVID in hospital survivors...
2.
Isfordink C, Boyd A, Mocroft A, Kusejko K, Smit C, De Wit S, et al.
Open Forum Infect Dis
. 2022 Nov;
9(10):ofac508.
PMID: 36320198
Background: Several studies have reported suboptimal efficacy of direct-acting antivirals (DAAs) to treat hepatitis C virus (HCV) subtypes endemic to sub-Saharan Africa (SSA) and Southeastern Asia (SEA). The extent of...
3.
Stirrup O, Blackstone J, Mapp F, MacNeil A, Panca M, Holmes A, et al.
Elife
. 2022 Sep;
11.
PMID: 36098502
Background: Viral sequencing of SARS-CoV-2 has been used for outbreak investigation, but there is limited evidence supporting routine use for infection prevention and control (IPC) within hospital settings. Methods: We...
4.
Agyeman A, You T, Chan P, Lonsdale D, Hadjichrysanthou C, Mahungu T, et al.
Br J Clin Pharmacol
. 2022 Aug;
88(12):5428-5433.
PMID: 36040430
Pharmacometric analyses of time series viral load data may detect drug effects with greater power than approaches using single time points. Because SARS-CoV-2 viral load rapidly rises and then falls,...
5.
Lee N, Murphy J, Al-Khudairi R, Sturdy A, Mahungu T, Haque T, et al.
Transfus Med
. 2022 Apr;
32(3):256-260.
PMID: 35474619
Aim: In the United Kingdom, organ donors/recipients are screened for evidence of human T-cell leukaemia virus type-1 and type-2 (HTLV-1/2) infections. Since the United Kingdom is a low prevalence country...
6.
Stirrup O, Boshier F, Venturini C, Guerra-Assuncao J, Alcolea-Medina A, Beckett A, et al.
BMJ Open Respir Res
. 2021 Sep;
8(1).
PMID: 34544733
Background: SARS-CoV-2 lineage B.1.1.7 has been associated with an increased rate of transmission and disease severity among subjects testing positive in the community. Its impact on hospitalised patients is less...
7.
Murray M, McIntosh M, Atkinson C, Mahungu T, Wright E, Chatterton W, et al.
J Infect
. 2021 Mar;
82(5):170-177.
PMID: 33753152
Objectives: To assess whether a commercially available CE-IVD, ELISA-based surrogate neutralisation assay (cPass, Genscript) provides a genuine measure of SARS-CoV-2 neutralisation by human sera, and further to establish whether measuring...
8.
Shrotri M, Harris R, Rodger A, Planche T, Sanderson F, Mahungu T, et al.
Emerg Infect Dis
. 2021 Mar;
27(4):1155-1158.
PMID: 33734962
Prospective serosurveillance of severe acute respiratory syndrome coronavirus 2 in 1,069 healthcare workers in London, UK, demonstrated that nucleocapsid antibody titers were stable and sustained for <12 weeks in 312...
9.
Mason C, Kanitkar T, Richardson C, Lanzman M, Stone Z, Mahungu T, et al.
J Antimicrob Chemother
. 2021 Jan;
76(5):1323-1331.
PMID: 33463683
Background: COVID-19 is infrequently complicated by bacterial co-infection, but antibiotic prescriptions are common. We used community-acquired pneumonia (CAP) as a benchmark to define the processes that occur in bacterial pulmonary...
10.
Warrell C, Pichl T, Cropley I, Mahungu T, Miller R
Br J Hosp Med (Lond)
. 2020 Dec;
81(11):1-4.
PMID: 33263478
No abstract available.